RE 19 (Atenolol 25 mg)
Pill imprint RE 19 has been identified as Atenolol 25 mg.
Atenolol is used in the treatment of high blood pressure; anxiety; alcohol withdrawal; ventricular tachycardia; angina (and more), and belongs to the drug class cardioselective beta blockers. There is positive evidence of human fetal risk during pregnancy. Atenolol 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RE 19 (Atenolol 25 mg)
- 25 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Cardioselective beta blockers
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium carbonate
silicon dioxide colloidal
sodium lauryl sulfate
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|21695-0322||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about atenolol
- Other brands: Tenormin